Emergent Biosolutions EBS Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingCostsAndExpenses.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's total costs & expenses?
- Emergent Biosolutions (EBS) reported total costs & expenses of $145.6M in Q1 2026.
- How has Emergent Biosolutions's total costs & expenses changed year-over-year?
- Emergent Biosolutions's total costs & expenses decreased by 15.5% year-over-year, from $172.3M to $145.6M.
- What is the long-term trend for Emergent Biosolutions's total costs & expenses?
- Over 4 years (2021 to 2025), Emergent Biosolutions's total costs & expenses has grown at a -18.2% compound annual growth rate (CAGR), from $1.43B to $642.8M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's operational efficiency and cost structure. Investors use this figure to evaluate how effectively management controls expenditures relative to total revenue generation.